Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

Thromboembolism is a compelling challenge in cancer care because of its life-threatening nature as well as its impact on specific treatments. Current guidelines do not generally recommend antithrombotic prophylaxis, except in selected categories of patients at high risk of thrombosis. Accordingly, s...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Medicine and Nursing
Oncology
ALK
anticoagulants
arterial thrombosis
cancer
cancer associated thrombosis
cancer-associated venous thromboembolism
chemotherapy
coagulation activation
coumarins
deep vein thrombosis
direct oral anticoagulant
direct oral anticoagulants
DOAC
DOACs
endogenous heparin
heparan sulfate
heparanase
Hodgkin lymphoma
hospice
integrated care
KRAS
locally advanced breast cancer
low molecular weight heparin
low molecular weight heparins
low-molecular weight heparin
low-molecular-weight heparin (LMWH)
lymphoma
malignancy
molecular subtype
multiple myeloma
n/a
neoplasms
Non-Hodgkin lymphoma
palliative care units
pancreatic cancer
pCR
prognostic model
prophylaxis
pulmonary embolism
risk assessment models
risk factors
ROS1
simultaneous care
survival
thromboprophylaxis
thrombosis
treatment
UFH
venous thromboembolism
VKA
VTE
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Internet

Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Similar Items